Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zai Lab Ltd (ZLAB) Guidance & Earnings Results

On 2025-11-06 Zai Lab Ltd raised guidance: "FY2025 revenue guidance raised to at least $460 million from prior guidance (not explicitly stated but implied…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZLABZai Lab LtdFollow ZLAB — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
2.7B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
6 Nov 25RaisedFY2025 revenue guidance raised to at least $460 million from prior guidance (not explicitly stated but implied raise). · full year
7 Aug 25ReaffirmedFY2025 revenue guidance $560-590M · full year

Zai Lab Ltd — questions

What guidance did Zai Lab Ltd give?
On 2025-11-06: "FY2025 revenue guidance raised to at least $460 million from prior guidance (not explicitly stated but implied raise)."
When does Zai Lab Ltd report earnings?
Zai Lab Ltd's next earnings report is expected on 2026-11-05.

Every figure on this page comes from Zai Lab Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.